PPD, Inc. Stock News

Strs Ohio trimmed its position in PPD, Inc. (NASDAQ:PPD) by 10.9% in the 3rd quarter, Holdings Channel.com reports. The fund owned 21,273 shares of the companys stock after selling 2,613 shares during the quarter. Strs Ohios holdings in PPD were worth $995,000 as of its most recent SEC filing. Other institutional investors and hedge funds []

PPD, Inc. (NASDAQ:PPD) major shareholder Corporate Investors Vii L. H&F sold 132,841,266 shares of PPD stock in a transaction on Wednesday, December 8th. The stock was sold at an average price of $47.50, for a total value of $6,309,960,135.00. The sale was disclosed in a document filed with the SEC, which can be accessed through [] The post PPD, Inc. (NASDAQ:PPD) Major Shareholder Corporate Investors Vii L. H&F Sells 132,841,266 Shares appeared first on ETF Daily News .

Nisa Investment Advisors LLC grew its holdings in shares of PPD, Inc. (NASDAQ:PPD) by 89.7% during the third quarter, HoldingsChannel.com reports. The firm owned 8,177 shares of the companys stock after acquiring an additional 3,867 shares during the quarter. Nisa Investment Advisors LLCs holdings in PPD were worth $383,000 as of its most recent filing []

WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research

IFM Investors Pty Ltd reduced its position in PPD, Inc. (NASDAQ:PPD) by 6.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,909 shares of the companys stock after selling 1,258 shares during the quarter. IFM Investors Pty Ltds holdings in PPD were worth []

Zacks Investment Research lowered shares of PPD (NASDAQ:PPD) from a hold rating to a sell rating in a research report sent to investors on Wednesday, Zacks.com reports. According to Zacks, PPD Inc. is a contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. It serves pharmaceutical, biotechnology, medical device, academic and []

The real world evidence solutions market is expected to witness market growth at a rate of 12.22% in the forecast period of 2021 to 2028 and is expected to reach USD 1,933.16 million by 2028. Data Bridge Market Research report

Related Stocks: ACRS , EPIX , CRIS , BGNE , RCKT , MRTX , CPNG , PPD , KSU , CHNG , FIVN , ARNA , WLTW , MXIM , ALXN , WORK , SOGO , GRUB ,

Marshall Wace LLP raised its holdings in shares of PPD, Inc. (NASDAQ:PPD) by 56.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 338,478 shares of the companys stock after buying an additional 121,878 shares during the period. Marshall Wace LLP owned about 0.10% of []

Charles Schwab Investment Management Inc. boosted its position in shares of PPD, Inc. (NASDAQ:PPD) by 13.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 346,896 shares of the companys stock after buying an additional 39,993 shares during the period. []

PPD, Inc. (PPD) CEO David Simmons on Q3 2021 Results - Earnings Call Transcript

PPD, Inc. (PPD) delivered earnings and revenue surprises of 16.22% and 7.22%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?